help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-118-1-138
Endocrinology Vol. 118, No. 1 138-142
Copyright © 1986 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DICKSON, R. B.
Right arrow Articles by LIPPMAN, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DICKSON, R. B.
Right arrow Articles by LIPPMAN, M. E.

Induction of Epidermal Growth Factor-Related Polypeptides by 17β-Estradiol in MCF-7 Human Breast Cancer Cells

R. B. DICKSON, K. K. HUFF, E. M. SPENCER and M. E. LIPPMAN

Medical Breast Cancer Section, Medicine Branch, National Cancer Institute, National Institutes of Health Bethesda, Maryland 20205;
Children’s Hospital of San Francisco San Francisco, California 94118

Address requests for reprints to: Dr. Marc E. Lippman, Medical Breast Cancer Section, National Cancer Institute, National Institutes of Health, Building 10, Room 12N226, Bethesda, Maryland 20205.

Abstract

MCF-7 human breast cancer cells release polypeptides related to insulin-like growth factor-I (IGF-I) and epidermal growth factor (EGF) into serum-free culture medium (CM). Treatment of MCF-7 cells with 17β-estradiol, which is required in vivo for MCF-7 tumor growth in the nude mouse and stimulates the MCF-7 growth rate in vitro, resulted in selectively enhanced growth factor activities in CM. Autostimulatory growth-promoting activity was elevated at least 2-fold, and EGFlike polypeptides were elevated 5-fold but IGF-I immunoreactivity was not elevated. Several species of estrogen-induced receptor- reactive EGF-like polypeptides, suggestive of high molecular weight transforming growth factor{alpha}, were detected after gel exclusion chromatography of CM extracted with 1 M acetic acid. A 30,000 mol wt peak of EGF receptor competing activity comigrated with a peak of autostimulatory and fibroblast-transforming activity. It is possible that estradiol stimulation of MCF- 7 growth and/or tumor formation may depend on induction of EGF-related polypeptide growth factors. EGF-I- and EGF-related polypeptides may act together as autocrine or paracrine growth factors in breast cancer. (Endocrinology 118: 138–142, 1985)

Received July 18, 1985.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Ciarloni, S. Mallepell, and C. Brisken
Amphiregulin is an essential mediator of estrogen receptor {alpha} function in mammary gland development
PNAS, March 27, 2007; 104(13): 5455 - 5460.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Bhandare, R. Nayar, M. Bryk, N. Hou, R. Cohn, N. Golewale, N. P. Parker, R. T. Chatterton, A. Rademaker, and S. A. Khan
Endocrine Biomarkers in Ductal Lavage Samples from Women at High Risk for Breast Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2620 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. R. Levin
Bidirectional Signaling between the Estrogen Receptor and the Epidermal Growth Factor Receptor
Mol. Endocrinol., March 1, 2003; 17(3): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo
Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. T. Baron, J. M. Lafky, C. H. Boardman, S. Balasubramaniam, V. J. Suman, K. C. Podratz, and N. J. Maihle
Serum sErbB1 and Epidermal Growth Factor Levels As Tumor Biomarkers in Women with Stage III or IV Epithelial Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 129 - 137.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Watabe, H. Kuramochi, Y. Furuya, N. Inagaki, S. Seino, S. Kimura, and J. Shimazaki
Identification of Histone H2A.X as a Growth Factor Secreted by an Androgen-independent Subline of Mouse Mammary Carcinoma Cells
J. Biol. Chem., October 11, 1996; 271(41): 25126 - 25130.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. DePasquale, W. Samsonoff, and J. Gierthy
17-beta-Estradiol induced alterations of cell-matrix and intercellular adhesions in a human mammary carcinoma cell line
J. Cell Sci., January 5, 1994; 107(5): 1241 - 1254.
[Abstract] [PDF]


Home page
ScienceHome page
R. Dickson, M. McManaway, and M. Lippman
Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth
Science, June 20, 1986; 232(4757): 1540 - 1543.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society